Wolfe Research upgrades Texas Instruments to outperform, sees cyclical recovery ahead

Wolfe Research upgraded Texas Instruments (TXN) to Outperform with a $230 price target, projecting a 24% upside, driven by the anticipated conclusion of its multi-year capital expenditure cycle. Analyst Chris Caso forecasts TXN's free cash flow to surge from approximately $2 billion in CY24 to over $9 billion by CY27 as CapEx is expected to significantly decline from 2026, positioning the company to benefit from an impending cyclical recovery in the analog chip industry after a period of underperformance.

Analysis

Wolfe Research has upgraded Texas Instruments (TXN) to an 'outperform' rating from 'peer perform', establishing a $230 price target which suggests a 24% upside. The core of this bullish thesis rests on the conclusion of the company's intensive, multiyear capital expenditure cycle initiated in early 2022, a period during which the stock has notably underperformed market benchmarks. The firm projects CapEx will decrease from $5 billion annually between 2023-2025 to a range of $2-5 billion in 2026, a strategic acceleration designed to leverage US CHIPS Act incentives before they end. This reduction in capital spending is forecast to dramatically improve financials, with free cash flow expected to surge from approximately $2 billion in CY24 to over $9 billion by CY27. This financial inflection point is complemented by an anticipated cyclical recovery in the analog chip industry, as Wolfe's channel checks indicate that customer inventory destocking has ceased, signaling a potential upcycle is imminent.

Key Decisions for Investors

• Investors should re-evaluate Texas Instruments based on the upcoming shift from a heavy capital expenditure phase to a period of significant free cash flow generation and potential gross margin growth.
• The 24% upside implied by the $230 price target, coupled with the stock's underperformance since 2022, may present a favorable entry point for those confident in the projected FCF expansion.
• Monitor for confirmation of the analog chip industry's cyclical recovery, as this industry-wide tailwind is a critical component of the upgrade thesis.
• Closely track future company guidance on capital expenditures post-2025 and progress on realizing the forecasted free cash flow surge to validate the long-term investment case.